Investor profile
The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) has backed 1 European tech company across 1 funding round in 2025, joining rounds totalling €16M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enterome | France | 1 | €16M |
